Development and implementation of an electronic admission-screening tool for Candidozyma auris (formerly Candida auris) at a large healthcare system in Miami, FL.
{"title":"Development and implementation of an electronic admission-screening tool for Candidozyma auris (formerly Candida auris) at a large healthcare system in Miami, FL.","authors":"Adriana Jimenez, Rossana Rosa, Nathalie Jean, Ashley Flanagan, Kelley Manzanillo Mshia, Gemma Rosello, Lilian M Abbo","doi":"10.1016/j.jhin.2025.08.012","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Candidozyma auris is an urgent public health threat pathogen worldwide. We describe using and implementing an electronic questionnaire to screen all patients for risk factors associated with C. auris upon admission to all facilities within a large healthcare system in Miami, Florida.</p><p><strong>Methods: </strong>We implemented a screening questionnaire within the electronic medical record (EMR) applied at the point-of-entry to all inpatient admissions. The tool asked about risk factors for C. auris colonization and included: previous history of C. auris, overnight hospital stay outside the United States in the last 12 months, tracheostomy or mechanical ventilation present on admission, transfer from a healthcare facility with high risk for C. auris, or history of carbapenemase-producing organism. The questionnaire triggered C. auris colonization testing using polymerase chain reaction (PCR) and initiation of contact precautions for those with identified risk(s).</p><p><strong>Results: </strong>During a 12-month period, the questionnaire was applied to 83,046 admissions. Of those, 4,401 (5.3%) had at least one risk factor for C. auris colonization. Of those tested, 166 (6.1%) were positive by PCR. The overall prevalence was 0.20%. The question with highest positivity was \"arriving from another healthcare facility\" (4.5%), and having a previous history of MDRO was the factor with the highest percent positivity on PCR (16%).</p><p><strong>Conclusion: </strong>Screening questionnaires incorporated in EMR are effective means to detect patients at risk for C. auris colonization, thus facilitating the early implementation of infection prevention and control measures aimed at avoiding the horizontal spread of highly transmissible organisms in healthcare facilities.</p>","PeriodicalId":54806,"journal":{"name":"Journal of Hospital Infection","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hospital Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhin.2025.08.012","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Candidozyma auris is an urgent public health threat pathogen worldwide. We describe using and implementing an electronic questionnaire to screen all patients for risk factors associated with C. auris upon admission to all facilities within a large healthcare system in Miami, Florida.
Methods: We implemented a screening questionnaire within the electronic medical record (EMR) applied at the point-of-entry to all inpatient admissions. The tool asked about risk factors for C. auris colonization and included: previous history of C. auris, overnight hospital stay outside the United States in the last 12 months, tracheostomy or mechanical ventilation present on admission, transfer from a healthcare facility with high risk for C. auris, or history of carbapenemase-producing organism. The questionnaire triggered C. auris colonization testing using polymerase chain reaction (PCR) and initiation of contact precautions for those with identified risk(s).
Results: During a 12-month period, the questionnaire was applied to 83,046 admissions. Of those, 4,401 (5.3%) had at least one risk factor for C. auris colonization. Of those tested, 166 (6.1%) were positive by PCR. The overall prevalence was 0.20%. The question with highest positivity was "arriving from another healthcare facility" (4.5%), and having a previous history of MDRO was the factor with the highest percent positivity on PCR (16%).
Conclusion: Screening questionnaires incorporated in EMR are effective means to detect patients at risk for C. auris colonization, thus facilitating the early implementation of infection prevention and control measures aimed at avoiding the horizontal spread of highly transmissible organisms in healthcare facilities.
期刊介绍：
The Journal of Hospital Infection is the editorially independent scientific publication of the Healthcare Infection Society. The aim of the Journal is to publish high quality research and information relating to infection prevention and control that is relevant to an international audience.
The Journal welcomes submissions that relate to all aspects of infection prevention and control in healthcare settings. This includes submissions that:
provide new insight into the epidemiology, surveillance, or prevention and control of healthcare-associated infections and antimicrobial resistance in healthcare settings;
provide new insight into cleaning, disinfection and decontamination;
provide new insight into the design of healthcare premises;
describe novel aspects of outbreaks of infection;
throw light on techniques for effective antimicrobial stewardship;
describe novel techniques (laboratory-based or point of care) for the detection of infection or antimicrobial resistance in the healthcare setting, particularly if these can be used to facilitate infection prevention and control;
improve understanding of the motivations of safe healthcare behaviour, or describe techniques for achieving behavioural and cultural change;
improve understanding of the use of IT systems in infection surveillance and prevention and control.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
